Diagnostics and Tools June 2024

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

Highlights from this edition:

• Moleculent closed a $26MM Series A Financing, led by Arch Venture Partners
• RareCyte closed a $20MM Growth Financing, led by Agilent Technologies, Inc. (NYSE:A), 5AM Venture Management, Arboretum Ventures, HealthQuest Capital, Impresa Management, Forest Road Company, Sheatree Capital, Gkcc
• BillionToOne, Inc. closed a $130MM Series D Financing, led by Premji Invest Limited